Michele Magni

7.1k total citations · 1 hit paper
96 papers, 5.2k citations indexed

About

Michele Magni is a scholar working on Oncology, Pathology and Forensic Medicine and Molecular Biology. According to data from OpenAlex, Michele Magni has authored 96 papers receiving a total of 5.2k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Oncology, 31 papers in Pathology and Forensic Medicine and 26 papers in Molecular Biology. Recurrent topics in Michele Magni's work include Lymphoma Diagnosis and Treatment (30 papers), Immunotherapy and Immune Responses (14 papers) and CAR-T cell therapy research (13 papers). Michele Magni is often cited by papers focused on Lymphoma Diagnosis and Treatment (30 papers), Immunotherapy and Immune Responses (14 papers) and CAR-T cell therapy research (13 papers). Michele Magni collaborates with scholars based in Italy, United States and United Kingdom. Michele Magni's co-authors include Massimo Di Nicola, Alessandro M. Gianni, Carmelo Carlo‐Stella, Paola Matteucci, Marco Milanesi, Paolo Longoni, Salvatore Grisanti, Elisabetta Albi, Jacopo Meldolesi and Atanasio Pandiella and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Blood.

In The Last Decade

Michele Magni

92 papers receiving 5.0k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli

2002 2.6k citations Massimo Di Nicola, Carmelo Carlo‐Stella et al. Blood profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michele Magni Italy	29	2.5k	1.7k	1.3k	1.0k	986	96	5.2k
Massimo Di Nicola Italy	37	2.9k 1.2×	2.0k 1.2×	2.7k 2.1×	2.1k 2.1×	1.1k 1.1×	160	7.5k
Volker Eckstein Germany	37	2.9k 1.2×	2.2k 1.3×	1.3k 1.0×	1.2k 1.2×	1.3k 1.3×	121	6.4k
Robert Möhle Germany	38	1.5k 0.6×	2.5k 1.5×	2.1k 1.6×	1.6k 1.6×	665 0.7×	82	6.3k
Berthold Streubel Austria	45	1.5k 0.6×	1.7k 1.0×	1.9k 1.5×	945 0.9×	918 0.9×	149	6.5k
William E. Janssen United States	27	1.2k 0.5×	1.1k 0.7×	1.3k 1.0×	1.0k 1.0×	432 0.4×	84	3.7k
Antonio Cuneo Italy	41	2.2k 0.9×	1.5k 0.9×	1.1k 0.9×	1.1k 1.1×	201 0.2×	243	5.1k
Saul J. Sharkis United States	28	2.1k 0.8×	4.3k 2.6×	969 0.8×	980 0.9×	1.5k 1.5×	66	7.5k
F. Richard Bringhurst United States	35	978 0.4×	3.4k 2.1×	2.4k 1.8×	733 0.7×	576 0.6×	75	6.6k
Paola Divieti Pajevic United States	35	1.1k 0.4×	3.4k 2.1×	2.2k 1.8×	878 0.8×	399 0.4×	73	6.8k
Christian P. Kratz Germany	37	681 0.3×	2.7k 1.7×	980 0.8×	908 0.9×	528 0.5×	151	4.9k

Countries citing papers authored by Michele Magni

Since Specialization

Citations

This map shows the geographic impact of Michele Magni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michele Magni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michele Magni more than expected).

Fields of papers citing papers by Michele Magni

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michele Magni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michele Magni. The network helps show where Michele Magni may publish in the future.

Co-authorship network of co-authors of Michele Magni

This figure shows the co-authorship network connecting the top 25 collaborators of Michele Magni. A scholar is included among the top collaborators of Michele Magni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michele Magni. Michele Magni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rivoltini, Licia, Chiara Camisaschi, Giovanni Fucà, et al.. (2024). Immunological characterization of a long-lasting response in a patient with metastatic triple-negative breast cancer treated with PD-1 and LAG-3 blockade. Scientific Reports. 14(1). 3379–3379. 6 indexed citations

Magni, Michele, et al.. (2023). Spontaneous hospitalization in the immediate aftermath of the manchester arena bombing. Journal of Contingencies and Crisis Management. 31(4). 627–634.

Magni, Michele, et al.. (2022). Combining Participatory Mapping and Geospatial Analysis Techniques to Assess Wildfire Risk in Rural North Vietnam. Environmental Management. 69(3). 466–479. 7 indexed citations

Pescaroli, Gianluca & Michele Magni. (2015). Flood warnings in coastal areas: how do experience and information influence responses to alert services?. Natural hazards and earth system sciences. 15(4). 703–714. 15 indexed citations

Zappasodi, Roberta, Marilena V. Iorio, Monica Tortoreto, et al.. (2014). Pleiotropic antitumor effects of the pan‐HDAC inhibitor ITF2357 against c‐Myc‐overexpressing human B‐cell non‐Hodgkin lymphomas. International Journal of Cancer. 135(9). 2034–2045. 17 indexed citations

Ruella, Marco, Andrea Riccardo Filippi, Anna Russo, et al.. (2011). Rituximab Followed by Involved Fields Radiotherapy (IF-RT) in Stage I-II Follicular Lymphoma (FL): Long Term Results,. Blood. 118(21). 3699–3699. 2 indexed citations

Zappasodi, Roberta, Serenella M. Pupa, Gaia C. Ghedini, et al.. (2010). Improved Clinical Outcome in Indolent B-Cell Lymphoma Patients Vaccinated with Autologous Tumor Cells Experiencing Immunogenic Death. Cancer Research. 70(22). 9062–9072. 114 indexed citations

Lavazza, Cristiana, Carmelo Carlo‐Stella, Arianna Giacomini, et al.. (2010). Human CD34+ cells engineered to express membrane-bound tumor necrosis factor–related apoptosis-inducing ligand target both tumor cells and tumor vasculature. Blood. 115(11). 2231–2240. 32 indexed citations

Devizzi, Liliana, Anna Guidetti, Corrado Tarella, et al.. (2008). High-Dose Yttrium-90–Ibritumomab Tiuxetan With Tandem Stem-Cell Reinfusion: An Outpatient Preparative Regimen for Autologous Hematopoietic Cell Transplantation. Journal of Clinical Oncology. 26(32). 5175–5182. 46 indexed citations

10.

Nicola, Massimo Di, Roberta Zappasodi, Carmelo Carlo‐Stella, et al.. (2008). Vaccination with autologous tumor-loaded dendritic cells induces clinical and immunologic responses in indolent B-cell lymphoma patients with relapsed and measurable disease: a pilot study. Blood. 113(1). 18–27. 94 indexed citations

11.

Cortelazzo, Sergio, Michele Magni, Corrado Tarella, et al.. (2007). Update of a GITIL Cohort Study: Frontline High Dose Sequential Chemotherapy with Rituximab and Autologous Stem Cell Transplantation Induces a High Rate of Long-Term Remissions in Patients with Mantle Cell Lymphoma. Blood. 110(11). 1282–1282. 4 indexed citations

12.

Lavazza, Cristiana, Carmelo Carlo‐Stella, Massimo Di Nicola, et al.. (2007). Highly efficient gene transfer into mobilized CD34+ hematopoietic cells using serotype-5 adenoviral vectors and BoosterExpress Reagent. Experimental Hematology. 35(6). 888–897. 5 indexed citations

13.

Devizzi, Liliana, Ettore Seregni, Anna Guidetti, et al.. (2006). High-Dose Myeloablative Zevalin Radioimmunotherapy with Tandem Stem-Cell Autografting Has Promising Activity, Minimal Toxicity and Full Feasibility in an Outpatient Setting.. Blood. 108(11). 3047–3047. 9 indexed citations

14.

Tarella, Corrado, Manuela Zanni, Massimo Di Nicola, et al.. (2005). High CR Rate and Prolonged EFS in aaIPI 2 – 3 Diffuse Large B-Cell Lymphoma Following High-Dose Sequential Chemotherapy and In Vivo Rituximab-Purged Stem Cell Autografting (R-HDS Regimen): Results of a Prospective Phase II Multicenter Study Sponsored by GITIL (Gruppo Italiano Terapie Innovative nei Linfomi).. Blood. 106(11). 2068–2068. 1 indexed citations

15.

Carlo‐Stella, Carmelo, Massimo Di Nicola, Paolo Longoni, et al.. (2004). Mobilization of primitive and committed hematopoietic progenitors in nonhuman primates treated with defibrotide and recombinant human granulocyte colony-stimulating factor. Experimental Hematology. 32(1). 68–75. 6 indexed citations

16.

Albi, Elisabetta, Stefania Pieroni, Michele Magni, & Claudia Sartori. (2003). Chromatin sphingomyelin changes in cell proliferation and/or apoptosis induced by ciprofibrate. Journal of Cellular Physiology. 196(2). 354–361. 29 indexed citations

17.

Magni, Michele, Massimo Di Nicola, Carmelo Carlo‐Stella, et al.. (2002). Identical rearrangement of immunoglobulin heavy chain gene in neoplastic Langerhans cells and B-lymphocytes: evidence for a common precursor. Leukemia Research. 26(12). 1131–1133. 29 indexed citations

18.

Bonfante, V., Simonetta Viviani, Liliana Devizzi, et al.. (2001). High-dose ifosfamide and vinorelbine as salvage therapy for relapsed or refractory Hodgkin's disease.. PubMed. 64. 51–5. 19 indexed citations

19.

Perfetti, Vittorio, et al.. (1999). Cells with clonal light chains are present in peripheral blood at diagnosis and in apheretic stem cell harvests of primary amyloidosis. Bone Marrow Transplantation. 23(4). 323–327. 14 indexed citations

20.

Pandiella, Atanasio, Michele Magni, & Jacopo Meldolesi. (1989). Plasma membrane hyperpolarization and [Ca2+]i increase induced by fibroblast growth factor in NIH-3T3 fibroblasts: Resemblance to early signals generated by platelet-derived growth factor. Biochemical and Biophysical Research Communications. 163(3). 1325–1331. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact